Fidelity Special Values PLC announces that on 22 October 2002 the Company
allotted 262,836 ordinary 25p shares at a price of 224 pence per share (which
represents a premium in excess of 2% over the latest net asset value.) Shares
purchased through the Fidelity Share Plan and the Fidelity ISA totaled 12836
and shares issued to Apollo Nominees Limited totaled 250,000. The new shares
will rank pari passu with existing ordinary 25p shares. A total of 3,915,650
shares now remain available for issue under the existing authority. The total
number of ordinary 25p shares now in issue is 42,544,014.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.